Skip to main content
Log in

Bedeutung für Ergebnis der Operation und Langzeitüberleben

Neoadjuvante Chemotherapie beim fortgeschrittenen Ovarialkarzinom

  • journal club
  • Published:
Info Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Vergote I et al. N Engl J Med. 2010;363(10):943–53.

    Article  CAS  PubMed  Google Scholar 

  2. Schwartz PE et al. Gynecol Oncol. 1999;72(1):93–9.

    Article  CAS  PubMed  Google Scholar 

  3. Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3-Leitlinie Diagnostik, Therapie und Nachsorge maligner Ovarialtumoren, Langversion 1.1, 2013, AWMF-Registernummer: 032/035OL, http://leitlinienprogramm-onkologie.de/Leitlinien.7.0.html

  4. Kehoe S et al. J Clin Oncol. 2013;31(suppl):abstr 5500.

    Google Scholar 

  5. du Bois A et al. Cancer. 2009;115(6):1234–44.

    Article  CAS  PubMed  Google Scholar 

Originalie

  • Fagö-Olsen CL et al. Does neoadjuvant chemotherapy impair long-term survival for ovarian cancer patients? A nationwide Danish study. Gynecol Oncol. 2014;132(2):292-8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sara Brucker.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brucker, S., Grischke, EM., Mahner, S. et al. Neoadjuvante Chemotherapie beim fortgeschrittenen Ovarialkarzinom. Info Onkol. 18, 14–17 (2015). https://doi.org/10.1007/s15004-015-0720-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-015-0720-1

Schlüsselwörter

Navigation